BioSig Technologies的禁闭协议于2025年11月12日结束,允许内幕人士在90天限制后出售股份。 
A lock-up agreement for BioSig Technologies ends on Nov. 12, 2025, allowing insiders to sell shares after a 90-day restriction.
公司的锁定协议将于2025年11月12日到期,结束了2025年8月13日开始的90至91天的限制. A lock-up agreement for BioSig Technologies, Inc. expires on November 12, 2025, ending a 90- to 91-day restriction that began August 13, 2025. 该协议与承保活动相关,禁止执行官、董事和某些股东出售或转让共同股票或可兑换证券。 The agreement, tied to an underwriting event, prohibits executives, directors, and certain shareholders from selling or transferring common stock or convertible securities. 它适用于各种工具,包括可兑换债券、限制性股票单位、优先股票、期权以及授权令。 It applies to various instruments including convertible debentures, restricted stock units, preferred stock, options, and warrants. 持有股票可以防止市场泛滥,并支持股票上市后的股价稳定. The hold prevents market flooding and supports stock price stability after a public offering.
